Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Tesla Raises Cybertruck Prices by $5,000 in US 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Add as a preferred source on Google
FRANKFORT, Ky., April 23, 2018 -- Farmers Capital Bank Corporation (NASDAQ:FFKT) (the “Company”) announced today that its Board of Directors (“Board”) approved a quarterly cash dividend on the Company’s common stock of $0.125 per share. The quarterly $0.125 per share dividend represents an annualized yield of 1.02% based on the closing price of $49.20 on April 20, 2018. The dividend is payable on July 2, 2018 to shareholders of record at the close of business on June 1, 2018. The Company currently has 7,519,814 shares outstanding.
Farmers Capital Bank Corporation is a bank holding company with one bank subsidiary, United Bank & Capital Trust Company. The Company is headquartered in Frankfort, Kentucky and operates 34 banking locations in 21 communities throughout Central and Northern Kentucky, and an insurance company. Its stock is publicly traded on the NASDAQ Stock Market LLC exchange in the Global Select Market tier under the symbol: FFKT.
Contact:
Lloyd C. Hillard, Jr.
President and Chief Executive Officer
502-227-1668
[email protected]
